USDOT confirms marijuana testing requirements will remain intact regardless of reclassification; Buttigieg assures transportation industry of exemption from DOJ's proposed rescheduling

Sample article from our Government & Public Policy

June 27, 2024 (press release) –

Jun 27, 2024

During a congressional hearing, Secretary Buttigieg provided this assurance to Rep. Crawford, who cited two ATA letters on the issue

Washington—During a House Committee on Transportation & Infrastructure hearing today, U.S. Department of Transportation Secretary Pete Buttigieg confirmed that his agency believes that the U.S. Department of Justice’s proposal to reschedule marijuana from a Schedule I to a Schedule III drug will not impact the transportation industry’s ability to screen for marijuana.
 
Secretary Buttigieg directed his comments to Congressman Rick Crawford (R-Arkansas), who cited two letters that the American Trucking Associations has sent to federal agencies seeking clarity on this major policy shift that could have negative consequences for highway safety.
 
“We are grateful to Congressman Crawford for elevating this serious issue, and we appreciate Secretary Buttigieg’s focus on providing the transportation industry with the clarity it needs to continue screening for marijuana use among safety-sensitive transportation workers,” said American Trucking Associations President & CEO Chris Spear.  “If the trucking industry’s ability to conduct drug testing for marijuana use were to be restricted, a heightened risk of impaired drivers would threaten our nation’s roadways.  DOT and ATA share the goals of achieving zero highway fatalities and ensuring the commercial driving workforce is qualified to safely operate, which is why we are committed to partnering with DOT to mitigate harmful impacts caused by the potential reclassification of marijuana.”
 
Marijuana and alcohol remain the most detected drugs in impaired driving crashes resulting in serious or fatal injuries.  Between 2000 and 2018, crash deaths involving marijuana more than doubled, from 9% to 21.5%.  Immediately following Canada’s 2018 legalization of marijuana, the country’s emergency rooms saw a 94% increase in the rate of marijuana-involved traffic injuries. 
 
In response to Congressman Crawford’s line of questioning today, Secretary Buttigieg explicitly stated that USDOT anticipates that it will maintain the authority to conduct testing of marijuana use by commercial motor vehicle drivers and other safety-sensitive transportation workers. 
 
“The American Trucking Associations has transmitted two letters to your agency highlighting [reclassification] concerns,” said Congressman Crawford.  “Mr. Secretary, I think it's safe to assume that the number of all impaired drivers on our roadways would increase.  Can you speak to what your Department is doing to ensure that transportation workers in safety reliant positions can continue to be tested for marijuana use if this proposal goes forward and how your Department plans to address transportation safety in light of DOJ's ruling?”
 
“Our understanding of the rescheduling of marijuana from Schedule I to Schedule III is that it would not alter DOT's marijuana testing requirements with respect to the regulated community,” said Secretary Buttigieg.  “For private individuals who are performing safety-sensitive functions, subject to drug testing, marijuana is identified by name, not by reference to one of those classes. So even if it was in its classification, we do not believe that that would have a direct impact on that authority.”
 

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order government & public policy coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy. We won't track your information when you visit our site. But in order to comply with your preferences, we'll have to use just one tiny cookie so that you're not asked to make this choice again.